FDA quietly says yes to a controversial abortion drug

Abortion. Just saying the word breathes heaviness. Even though there were 609,360 abortions across 48 reporting areas in 2022 ...
BMJ Open

Effectiveness of educational interventions in general practice for improving medication appropriateness and deprescribing in older adults: a systematic review protocol

Introduction Polypharmacy in older adults is a growing concern, particularly in general practice (GP), where general practitioners (GPs) are the main prescribers managing complex multimorbidity. While ...
The Logan Daily News

Ohio launches first mobile medication units to expand access to lifesaving treatment

On Friday, representatives with the Ohio Department of Behavioral Health (DBH), Anchor Addiction and Wellness Center, and the ...

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight ...

Detailed price information for Aspire Biopharma Holdings Inc (ASBP-Q) from The Globe and Mail including charting and trades.
The American Journal of Managed Care

Manual Push Delivery of Rozanolixizumab for gMG Preferred by Patients

Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...

FDA unveils drugs to receive expedited review in support of ‘national priorities’

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...